BioCryst Pharmaceuticals (BCRX)
BioCryst Pharmaceuticals Revenues: 12.22M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
BCRX Revenues Rankings
| Overall | 15th percentile | 3732 of 4425 |
| Sector | 35th percentile | 301 of 470 in Healthcare |
| Industry | 56th percentile | 58 of 132 in Biotechnology |
BCRX Revenues Range, Past 5 Years
| Minimum | 2.659M | Jun 2008 |
| Maximum | 54.90M | Dec 2009 |
| Average | 14.37M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these BCRX related companies
BCRX News
$BCRX 200 Day SMA Cross - Price crossed below 200 day SMA (3.3748). Confirmed by volume.
about 6 days ago by TradeIdeasQuant
about 6 days ago by TradeIdeasQuant
RT @adamfeuerstein RA Capital goes in for 3M shares of $BCRX during Q1. Also 2.3M shares of $YMI and smallish 300K shares of $VVUS. 13F
about 11 days ago by WolfsBiotechs
about 11 days ago by WolfsBiotechs
@adamfeuerstein Adam, what is your take on $BCRX ? Know anything about them?
about 12 days ago by faststop1
about 12 days ago by faststop1
Savient (SVNT) Shares Hit as BioCryst (BCRX) Gets FDA Guidance for Gout Treatment Approval
May 07, 12:32PM Street Insider
May 07, 12:32PM Street Insider
Listen to $BCRX Q1 2012 earnings call - live at 11:00 AM, ondemand after - http://stks.co/3hVI
about 21 days ago by earningscast
about 21 days ago by earningscast
BioCryst Pharma (BCRX) Posts Narrower than Expected Q1 Loss of 13c/Share; Reaffirms
May 07, 6:32AM Street Insider
May 07, 6:32AM Street Insider
BioCryst Provides Corporate Update and Reports First Quarter 2012 Financial Results
May 07, 6:30AM Business Wire
May 07, 6:30AM Business Wire
$BCRX forms bearish "Head and Shoulders Top" chart pattern. http://stks.co/3apt
about 27 days ago by RecogniaEvents
about 27 days ago by RecogniaEvents
$BCRX http://stks.co/36kk here's one beauty of a flag on the daily--keep on radar my friends!
about 61 days ago by jrtrader1998
about 61 days ago by jrtrader1998
$BCRX sweet looking flag on this one -- coiled so tightly right now -- looking for a break on this - probably to the upside
about 63 days ago by DMAugustine
about 63 days ago by DMAugustine
$BCRX Upside Blowoff - 15 Minute Down Reversal - Red bar after 10 higher highs and higher lows
about 75 days ago by TradeIdeasQuant
about 75 days ago by TradeIdeasQuant
$BCRX is -5.9% down since open on unusual high volume and -10.8% down since close.
about 76 days ago by TradeBot
about 76 days ago by TradeBot
Monday's High Tight Flags $BCRX $ALIM $KTCC $VVUS $OREX http://chart.ly/spytjaq
about 77 days ago by Woodshedder
about 77 days ago by Woodshedder
$BCRX Upside Blowoff - 15 Minute Down Reversal - Red bar after 4 green bars
about 82 days ago by TradeIdeasQuant
about 82 days ago by TradeIdeasQuant
$BCRX is 5.5% up since open on unusual high volume and 5.9% up since close.
about 82 days ago by TradeBot
about 82 days ago by TradeBot
$BCRX -filled @ $4.71. Taking half the risk off the table & moving the stop up to $4.11 from an initial stop of $3.53 http://stks.co/2ht8
about 82 days ago by TraderFoxxx
about 82 days ago by TraderFoxxx
$BCRX New 52 Week High - Crossed daily highs resistance. Next resistance 5.84 from 12/28/2010.
about 82 days ago by TradeIdeasQuant
about 82 days ago by TradeIdeasQuant
$BCRX Spiking Higher; Spokesperson Attributes to Appearance at Cowen Health Care Conference in Boston
about 83 days ago by Benzinga
about 83 days ago by Benzinga
$BCRX Upside Blowoff - 15 Minute Down Reversal - Red bar after 4 green bars with higher highs and higher lows
about 83 days ago by TradeIdeasQuant
about 83 days ago by TradeIdeasQuant
$BCRX New 52 Week High - Crossed daily highs resistance. Next resistance 5.00 from 1/13/2011.
about 83 days ago by TradeIdeasQuant
about 83 days ago by TradeIdeasQuant
Trade Signal-New $BCRX -BTO @ 4.69 Limit -w/3.53 Stop on the Wkly Chart w/.5N @ Risk http://chart.ly/kahgw6q
about 84 days ago by TraderFoxxx
about 84 days ago by TraderFoxxx
$BCRX New 52 Week High - Crossed daily highs resistance. Next resistance 4.85 from 1/14/2011.
about 87 days ago by TradeIdeasQuant
about 87 days ago by TradeIdeasQuant
Biocryst (BCRX) Shares Surge 28+% Following Data from Studies of BCX5191
Feb 15, 7:34AM Street Insider
Feb 15, 7:34AM Street Insider
BioCryst Announces Promising Results from Preclinical Studies of BCX5191 for Hepatitis C
Feb 15, 6:00AM Business Wire
Feb 15, 6:00AM Business Wire
BioCryst to Announce Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012
Feb 06, 6:45AM Business Wire
Feb 06, 6:45AM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BCRX | 3.26 | +0.00 | +0.00% | 150.09M |
| BOSC | 0.7601 | -0.00 | -0.51% | 3.398M |
| BORN | 2.64 | -0.08 | -2.94% | 67.93M |
| BOOM | 17.41 | -0.22 | -1.25% | 234.69M |
| BONT | 4.02 | +0.08 | +2.03% | 79.19M |
| BONE | 1.55 | -0.06 | -3.73% | 63.30M |
| BONA | 5.67 | +0.07 | +1.25% | 344.74M |
| BOLT | 12.59 | +0.35 | +2.86% | 108.02M |
| BOKF | 56.52 | -0.35 | -0.62% | 3.946B |
| BOH | 47.42 | -0.34 | -0.71% | 2.181B |